|
I
N
D
I
A
N
M
E
D
I
C
I
N
A
L
P
L
A
N
T
S
|
|
|
d) In biotechnologically
developed new varieties and transgenic plants, even if the plant species
are somehow ascribed to a particular country, what of the almost globally
distributed micro-organisms used in the process?
e) Natural products
cannot be patented but the processing of the products can be. Product
patenting is coming into force, but will not be easy to implement.
Clearly, all the issues
related to the protection of material and intellectual property rights on
medicinal plants are steeped in controversies. Each party interested in
the issue tries to gain the maximum advantage. While the need for
protection is recognised, the means are not agreed upon. Very serious
efforts on the part of the scientific community and the Government of
India are needed to evolve internationally acceptable patent rights
legislation.
REFERENCES
Dhar, B. and Nagaraja Rao,
C. 1999. Plant breeders and farmers in the new intellectual property
regime: conflict of interests? In Biotechnology, biosafety, and
biodiversity. (eds.) Shantharam, S. and Montgomery, J.F. Science
Publishers, Inc., New Hampshire. pp 177-190.
Gadgil, M. and Devasia,
P. 1995. Intellectual property rights and biological resources: specifying
geographical origins and prior knowledge of uses. Curr. Sci., 69: 637-639.
Ganguli, P. 1998. Gearing
for patents: the Indian scenario. Universities Press, Hyderabad.
Prakash, S. 1999. The IPR
debate for India. In Biotechnology, biosafety, and biodiversity.
(eds.)
Shantharam,
S. and Montgomery, J.F. Science Publishers, Inc., New Hampshire. pp
225-226.
Seghal, S. 1999. The IPR
controversy and the Indian seed industry. In Biotechnology, biosafety,
and biodiversity. (eds.) Shantharam, S. and Montgomery, J.F. Science
Publishers, Inc., New Hampshire. pp 207-218.
Swaminathan, M.S. 1993. A
plant variety protection for India. Vatika, winter, pp 7-12.
|